MeSH tree: E01.370.350.710
The immune system is the body's protector. Following the detection of a potential threat, such as a bacterial or viral infection, a healthy immune system will attack the foreign invader. What many people don't realize is ...
Jun 16, 2025
0
41
In modern immunotherapy, modified immune cells are introduced into the body to attack tumors and other targets. Researchers at the Technical University of Munich (TUM) have developed a method for tracking these cells in the ...
Jun 13, 2025
0
19
Depression and bipolar disorder of late onset may represent more than just mental health conditions. Growing evidence suggests these late-life mood disorders (LLMDs) could be not merely risk factors, but rather early warning ...
Jun 9, 2025
0
14
Alzheimer's disease, marked by memory loss, trouble concentrating and thinking, and changes in personality and behavior, devastates patients, their families and loved ones. With new treatments available for people with early ...
Jun 6, 2025
0
41
Researchers from The University of Texas at Dallas' Center for Vital Longevity (CVL) have released the full dataset from a decade-long project designed to track brain and cognitive health as people age and distinguish neurologically ...
May 29, 2025
0
19
Rural Georgians may find it difficult to access medication that could slow the progression of Alzheimer's disease, according to a new study from the University of Georgia.
May 27, 2025
0
12
Diabetes is characterized by the pancreas producing too little insulin, but there is a rarer condition in which it produces too much. A hormone-producing tumor originating in the pancreas—an insulinoma—is the cause. Patients ...
May 22, 2025
0
13
The United States on Friday approved the first blood test for Alzheimer's, a move that could help patients begin treatment earlier with newly approved drugs that slow the progression of the devastating neurological disease.
May 17, 2025
0
588
Learning about one's risk for Alzheimer's disease may not lead to emotional distress, but motivation to maintain healthy lifestyle changes tends to fade over time, even in people at high risk, according to a study involving ...
May 7, 2025
0
52
A new study conducted at Cedars-Sinai reveals how the cholesterol-reducing drug evolocumab prevents heart attacks in people with coronary artery disease—a leading cause of death in the United States.
May 6, 2025
0
38
